Publications

Author

Title

Year sorteringsordning

Fulltext

Wärnberg, Fredrik
Garmo, Hans
Emdin, Stefan; et al.

Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS trial
Journal of Clinical Oncology, 32(32): 3613-3618

2014

-

Klintman, M.
Nilsson, Fredrik
Bendahl, P. -O; et al.

A prospective, multicenter validation study of a prognostic index composed of S-phase fraction, progesterone receptor status, and tumour size predicts survival in node-negative breast cancer patients: NNBC, the node-negative breast cancer trial
Annals of Oncology, 24(9): 2284-2291

2013

-

Holmberg, L.
Wong, Y. N. S.
Tabar, L.; et al.

Mammography casting-type calcification and risk of local recurrence in DCIS: analyses from a randomised study
British Journal of Cancer, 108(4): 812-819

2013

-

Holmberg, Lars
Garmo, Hans
Granstrand, Bengt; et al.

Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast.
J Clin Oncol, 26(8): 1247-52

2008

-

Ringberg, A
Nordgren, H
Thorstensson, S; et al.

Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast--results from the Swedish randomised trial.
Eur J Cancer, 43(2): 291-8

2007

-

Emdin, Stefan
Granstrand, Bengt
Ringberg, Anita; et al.

SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening.
Acta Oncol, 45(5): 536-43

2006

-

Dejmek, Janna
Leandersson, Karin
Manjer, Jonas; et al.

Expression and signaling activity of Wnt-5a/discoidin domain receptor-1 and Syk plays distinct but decisive roles in breast cancer patient survival.
Clin Cancer Res, 11(2 Pt 1): 520-8

2005

-

Rydén, Lisa
Stendahl, Maria
Jonsson, Håkan; et al.

Tumor-specific VEGF-A and VEGFR2 in postmenopausal breast cancer patients with long-term follow-up: Implication of a link between VEGF pathway and tamoxifen response
Breast Cancer Research and Treatment, 89(2): 135-143

2005

-

Ljuslinder, Ingrid
Malmer, Beatrice
Golovleva, Irina; et al.

Increased copy number at 3p14 in breast cancer
Breast Cancer Research, 7(5): R719-R727

2005

-

Svensson, Sofie
Jirström, Karin
Rydén, Lisa; et al.

ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis
Oncogene, 24(27): 4370-4379

2005

-